[Robotically assisted coronary artery bypass grafting on beating heart].

Area of Science:

• Cardiovascular Surgery
• Minimally Invasive Cardiac Surgery
• Robotic Surgery

Context:

• Coronary artery bypass grafting (CABG) is a standard treatment for coronary artery disease.
• Minimally invasive approaches aim to reduce surgical trauma and improve recovery.
• Robotic systems offer enhanced precision and dexterity for complex surgical tasks.

Purpose:

• To evaluate the safety and efficacy of robotically assisted coronary artery bypass grafting (RACABG) on a beating heart.
• To assess graft flow and patency rates following RACABG.
• To determine the feasibility of RACABG for both single and multi-vessel coronary artery disease.

Summary:

• 105 patients underwent RACABG on a beating heart using the da Vinci S system via minithoracotomy.
• The procedure involved harvesting internal mammary arteries and anastomosing them to coronary targets.
• Mean graft flow was 21 ± 13 ml/min, with all grafts patent on follow-up (mean 30 ± 12 months).
• No deaths, strokes, or reinterventions occurred; patients were discharged without complications.

Impact:

• RACABG on a beating heart is a safe and advanced revascularization strategy.
• This technique is suitable for patients with single and multi-vessel coronary artery disease.
• The da Vinci S system facilitates precise execution of complex bypass procedures.